Can-fite

Developer of small molecules for autoimmune-inflammatory and cancer diseases

placePetah Tikva, Central District, Israel calendar_todayFounded 1994 groups8 employees language canfite.com

Innovation

53 patent families (21 granted) — focus: Human necessities, Physics & computing, Chemistry & metallurgy; filing pace steady. Cited 914 times.

YearFilings
20156
20164
20174
20184
20194
20204
20215
20223
20237
20245
20257
20262

Investor mix

6 investors on record; lead investors include Giza Venture Capital.

Investor typeCountShare
Venture capital467%
Other / undisclosed233%
Coming soon